BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
Mechanistic comparison of curculigo orchioides and mylabris phalerata based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
curculigo and mylabris share 1870 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.513 means 51% of the combined target set is bound by both compounds. The IDF-weighted score of 0.492 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do curculigo and mylabris have in common?
curculigo and mylabris share 1870 molecular targets with a Jaccard similarity of 51%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can curculigo and mylabris be combined?
curculigo and mylabris share 1870 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: curculigo or mylabris?
In the BiohacksAI corpus: curculigo has 116 PubMed-indexed studies, mylabris has 37 studies.